Boston Scientific (XSWX:BSX) Institutional Ownership: 59.03% (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:BSX Boston Scientific Corp XSWX:BSX
74 GF Score
Price CHF35.59
GF Value CHF85.51
! 1 Warning Sign
View Full Analysis

What is Boston Scientific Institutional Ownership?

Boston Scientific XSWX:BSX -1.21% 74 Institutional Ownership is 59.03% as of Jul. 19, 2026. GuruFocus rates XSWX:BSX with a GF Score™ of 74/100 and a GF Value™ of CHF85.51. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Boston Scientific's institutional ownership is 59.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Boston Scientific's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Boston Scientific's Float Percentage Of Total Shares Outstanding is 99.90%.

Boston Scientific Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Boston Scientific's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific Institutional Ownership Chart

Boston Scientific Historical Data

The historical data trend for Boston Scientific can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 65.31 64.84 64.25 62.64 63.55 63.74 61.18 60.47 60.15 59.03
XSWX:BSX
74GF Score
Boston Scientific Corp XSWX:BSX
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boston Scientific Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 59.03% mean?
Boston Scientific (XSWX:BSX) has a Institutional Ownership of 59.03% as of Jul. 19, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Boston Scientific and its competitors.
Is Boston Scientific's Institutional Ownership too high?
Boston Scientific's current Institutional Ownership is 59.03%. Overall, Boston Scientific has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Institutional Ownership compare to EW and GEHC?
Boston Scientific's Institutional Ownership of 59.03% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Boston Scientific and its competitors. Boston Scientific's current Institutional Ownership is 59.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Boston Scientific (XSWX:BSX) has a current Institutional Ownership of 59.03%. The stock's GF Value™ is CHF85.51, compared to a current price of CHF35.59 — trading 58.4% below its estimated fair value. The current Institutional Ownership is 59.03%. Boston Scientific's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Boston Scientific (XSWX:BSX), the current Institutional Ownership is 59.03% as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boston Scientific (XSWX:BSX) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of CHF35.59 is trading 58.4% below its estimated GF Value™ of CHF85.51.

Key valuation signals for XSWX:BSX:

  • Institutional Ownership: 59.03%
  • GF Value™: CHF85.51 vs. price of CHF35.59 (58.4% below fair value)
  • GF Score™: 74/100 with 1 warning sign

No single metric tells the full story. See the XSWX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
74GF Score

Get the complete analysis for XSWX:BSX

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF35.59
Price
CHF85.51
GF Value